DWDongming Wang

Dongming Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dongming Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Hajra Zafar

    School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan, Road, Shanghai 200240, China

    1 shared publication
  • Long Lv

    Central Laboratory, Gaochun Hospital Affiliated to Jiangsu University, Nanjing, China

    1 shared publication
  • Pengfei Xue

    Medical School of Southeast University, Nanjing, China

    1 shared publication
  • Yi Wang

    Department of Orthopaedics, Jiujiang Traditional Chinese Medicine Hospital, Jiujiang, China

    1 shared publication
  • Yuhang Yang

    Department of Orthopedics, Nanjing Gaochun People’s Hospital, Gaochun Economic Development Zone, Nanjing, China

    1 shared publication
  • Yunduan Que

    Department of Orthopedics, Nanjing Gaochun People’s Hospital, Gaochun Economic Development Zone, Nanjing, China

    1 shared publication

Latest Publications

  • Roles of Chemokines in Intervertebral Disk Degeneration

    by Pengfei Xue, Yi Wang, Long Lv, Dongming Wang, Yuntao Wang

    Purpose of Review Intervertebral disc degeneration is the primary etiology of low back pain and radicular pain. This review examines the roles of crucial chemokines in different stages of degenerative disc disease, along with interventions targeting chemokine function to mitigate disc degeneration. Recent Findings The release of chemokines from degenerated discs facilitates the infiltration and activation of immune cells, thereby intensifying the inflammatory cascade response. The migration of immune cells into the venous lumen is concomitant with the emergence of microvascular tissue and nerve fibers. Furthermore, the presence of neurogenic factors secreted by disc cells and immune cells stimulates the activation of pain-related cation channels in the dorsal root ganglion, potentially exacerbating discogenic and neurogenic pain and intensifying the degenerative cascade response mediated by chemokines. Summary Gaining a deeper comprehension of the functions of chemokines and immune cells in these processes involving catabolism, angiogenesis, and injury detection could offer novel therapeutic avenues for managing symptomatic disc disease.


  • Open Access

    Tetracycline-grafted mPEG-PLGA micelles for bone-targeting and osteoporotic improvement

    by Yunduan Que, Yuhang Yang, Hajra Zafar, Dongming Wang

    Aim: We aimed to create a nano drug delivery system with tetracycline (TC)-grafted methoxy poly-(ethylene-glycol)‒poly-(D, L-lactic-co-glycolic acid) (mPEG‒PLGA) micelles (TC‒mPEG‒PLGA) with TC and mPEG‒PLGA for potential bone targeting. Prospectively, TC‒mPEG‒PLGA aims to deliver bioactive compounds, such as astragaloside IV (AS), for osteoporotic therapy.Methods: Preparation and evaluation of TC‒mPEG‒PLGA were accomplished via nano-properties, cytotoxicity, uptake by MC3T3-E1 cells, ability of hydroxyapatite targeting and potential bone targeting in vivo, as well as pharmacodynamics in a rat model.Results: The measured particle size of AS-loaded TC‒mPEG‒PLGA micelles was an average of 52.16 ± 2.44 nm, which exhibited a sustained release effect compared to that by free AS. The TC‒mPEG‒PLGA demonstrated low cytotoxicity and was easily taken by MC3T3-E1 cells. Through assaying of bone targeting in vitro and in vivo, we observed that TC‒mPEG‒PLGA could effectively increase AS accumulation in bone. A pharmacodynamics study in mice suggested potentially increased bone mineral density by AS-loaded TC‒mPEG‒PLGA in ovariectomized rats compared to that by free AS.Conclusion: The nano drug delivery system (TC‒mPEG‒PLGA) could target bone in vitro and in vivo, wherein it may be used as a novel delivery method for the enhancement of therapeutic effects of drugs with osteoporotic activity.